Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
769.4 EUR | -0.08% | +2.09% | +46.34% |
08:15am | US FDA Staff Flags Potential Limited Benefit of Eli Lilly's Alzheimer's Disease Drug | MT |
Jun. 06 | US FDA panel to vote on data, risk profile of Lilly Alzheimer's drug | RE |
- Stock Market
- Equities
- LLY Stock
- LLY Stock
- News Eli Lilly and Company